Production, quality control and biological evaluation of 153Sm-TTHMP as a possible bone palliation agent

Document Type : Original Article

Authors

1 Inorganic Chemistry Department, Faculty of Sciences, Tehran University, Tehran, Iran

2 Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, Iran

Abstract

Introduction: Various bone palliative therapeutic agents have been developed and widely used for bone metastasis such as 153Sm-EDTMP. In this study, production, quality control and biodistribution studies of a newly developed therapeutic compound have been presented followed by imaging studies in wild-type rodents.
Methods: 153Sm-TTHMP was prepared starting from 153Sm-SmCl3, prepared by neutron activation of an enriched 152Sm sample (purity >98%), and in-house synthesized TTHMP in 1h at 25°C followed by stability tests, partition coefficient determination and biodistribution studies of in wild-type rodents using scarification and SPECT imaging.
Results: The radiolabled Sm complex was prepared in high radiochemical purity (>99%, ITLC) and specific activity of 278 GBq/mmol and demonstrated significant stability at 4, 25 and 37°C (in presence of human serum). Initial biodistribution data showed significant bone accumulation of the tracer in 48h.
Conclusion: 153Sm-TTHMP can be a potential candidate for bone pain palliation therapy in skeletal metastases, although further biological studies in other mammals is still needed.

Keywords

Main Subjects

Iranian Journal of Nuclear Medicine
Volume 19, Issue 2 - Serial Number 36
Serial number: 36
December 2011
Pages 60-68

Files

Share

How to cite

Statistics